The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...

Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.

Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...

Neurologist Dr. Leah Croll talks about the new research suggesting they might help in treating people with alcohol use ...

New research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May) and published in the ...

Weight loss jabs, also known as GLP-1 receptor agonists, work by reducing food cravings. Giving obese children weight-loss ...

According to a recent Kaiser Family Foundation poll, roughly 6% of U.S. adults are currently taking GLP-1 for weight loss, ...

The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.

Experts say weight management drugs have created an unsustainable surge in health care spending, with some insurance ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in ...